Friday, February 20, 2015 12:28:18 PM
GOTTA KNOW WHAT YOU OWN HERE!
1) Melanoma initiated 1Q - Merck
2) Squamous Cell Carcinoma of the Head and Neck (SCCHN) initiated 1Q
Dr. Mai H. Le, Chief Medical Officer at OncoSec, stated, “Similar to melanoma, recent data suggest that in SCCHN, tumor-infiltrating lymphocytes [TILs] are required to achieve responses to anti-PD-1 drugs such as pembrolizumab. We believe that as a single agent, IL-12 ImmunoPulse has the potential to convert tumors from a low to a high-TIL state.”
Heat Biologic is presently in P2 with the follow indications:
3)Lung
AND
4) Bladder 80% and 75% patients respectively, do not respond to Heat Biologics "Impact" drug.
Article Head line of ZACKS from three month ago needs to be updated from
This 1st Quarter's success in increasing the immunogenicity of cancerous tumors is a make-or-break moment in OncoSec moment in immunotherapy history. I realize they have a fledgling drug development program, but drugs are slow movers through the FDA approval program. The next three to six months must yield, with a degree of consistency across all the above mentioned indications, the power to Make responders out of Non-responders.
So What's at stake for ONCS PPS: I think that if ImmunoPulse performs as expected, the PPS should determined by "billions" in revenue not millions. It helps if you Stop thinking like a trader and start thinking like an institutional investor--then you know the data about the TIL's is yet to come. IT'S ALL ABOUT THE TIL's! Which means for right now, its all about waiting for Trials.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM